Last reviewed · How we verify
NCT04674293: IVT-AIS-R
Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
trial testing Revelisa in The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase in 500 participants. Status unknown.
1 December 2020
Quick facts
| Lead sponsor | Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 1 January 2020 |
| Primary completion | 1 December 2020 |
| Estimated completion | 1 January 2022 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- Revelisa — full drug profile →
Conditions studied
- The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase — all drugs for The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase →
Sponsor
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Who can join
Adults 18 to 80, any sex, with The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Russian prospective multicenter registry study of intravenous thrombolytic therapy for acute ischemic stroke.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04674293
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health trials
Trials by the same sponsor.
- NCT06802159 — Rehabilitation Methods for Unilateral Spatial Neglect in Stroke Patients · NA · recruiting
- NCT06299943 — Biofeedback Gait Training by Target Biomechanical Parameters in the Early Recovery Period of Stroke · NA · unknown
- NCT05309148 — Oculomotor and Cognitive Rehabilitation Using Visual Feedback in Stroke Patients · NA · unknown
- NCT06143475 — Functional Proprioceptive Stimulation of the Upper Limbs in Stroke Patients · NA · completed
- NCT04681235 — Virtual Reality Training Affects on Motor Functions and Mental Health in Stroke Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04674293 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
- Last refreshed: 19 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04674293.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing